We recently published Jim Cramer Didn’t Hold Back On SpaceX’s IPO & Discussed These 12 Stocks. Eli Lilly and Company (NYSE:LLY) is one of the stocks discussed by Jim Cramer. Healthcare and pharmaceuti
In the closing of the recent trading day, Eli Lilly (LLY) stood at $1, denoting a -2.41% move from the preceding trading day.
While the market fixates on the STELARA patent cliff, the rest of the business is quietly accelerating. Excluding the legacy drug, Johnson & Johnson (JNJ) grew in double digits for the quarter. The In
Management raised the bar two months ago, but the stock just shrugged. Here’s why the market is waiting for proof, not promises.
Eli Lilly (NYSE:LLY) has invested in Abridge, an AI-focused clinician documentation company. The partnership connects Lilly to Abridge's clinical conversation data platform, used across hundreds of he
Eli Lilly's obesity drug franchise is a juggernaut, but a surprisingly large share of its success relies on price-sensitive consumers.
Thursday’s unusual options activity had plenty to choose from. However, it was the LEAPS that were really worth considering for bullish investors. Of the 28 calls over 365 days, these three quality st
With the massive SpaceX debut hogging the headlines, some retail investors may have allowed more prosaic names to slip from their minds. Pharma stock Eli Lilly is trading in a buy zone as institution
View interactive chart, options flow, and AI analysis for LLY on Zorveq Finance.
Open LLY Chart & Analysis →